Pierluigi Paracchi has joined the Advisory Board of Aurora Fund of Funds. Aurora is a leading tech Fund of Funds platform able to cover global opportunities in multi sector strategies such as ICT, Life Sciences and Deep Tech sectors in the Venture Capital space, combining primary investments, co-investments and secondary transactions.
Pierluigi Paracchi is co-founder and Chairman & CEO at Genenta Science (a clinical stage company developing a gene therapy strategy for tumor treatment which has raised €32.1M), Pierluigi has +20 years of experience in Life Sciences and ICT, as venture capitalist and board member of some of the most relevant companies in the biotech space and as Founder and CEO of Quantica SGR (i.e. investor and Board Member in the biotech start-up EOS, exited in 2013 for $200M upfront + $220M milestones). He was also a Venture Consultant for Sofinnova Partners and is currently Venture Partner at AAS (EU biotech VC baked by two multinational pharma companies) and co-founder and Board Member at Altheia Science (autoimmune diseases, €17M as Series A). His long track record in healthcare, life sciences and subsectors will most certainly lead to maximizing the benefits for our investors. Pierluigi was also a founding member of Axon back in 2006 and has always been supporting Axon’s developments since then.
We welcome Pierluigi to Aurora’s tech platform, what we expect to become one of the best technology access vehicles for institutional investors worldwide.
Read The Investment Strategy of Aurora Fund Of Funds in the following link